Procter & Gamble Health Ltd - P & G HEALTH LTD Share Price

Sector: Pharmaceuticals | ISIN: INE199A01012
₹ 5,112.90 (0.05%) icon29 Sep, 2023, 3:47:51 PM
Open
₹ 5,134.65
Prev. Close
₹ 5,110.10
Turnover(lac)
₹ 158.04
Day's High
₹ 5,135.70
Day's Low
₹ 5,064.65
52 Wk High
₹ 5,500.00
52 Wk Low
₹ 3,870.10
Book Value
₹ 509.61
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 8,487.41
P/E
36.99
EPS
138.23
Div. Yield
1.86

Procter & Gamble Health Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 9/29/2023 3:47:51 PM

    ₹ 5112.9 2.80 0.05
  • Open
  • ₹ 5,134.65
  • Prev. Close
  • ₹ 5,110.1
  • Turnover(Lac.)
  • ₹ 158
  • Day's High
  • ₹ 5,135.7
  • Day's Low
  • ₹ 5,064.65
  • 52 Week's High
  • ₹ 5,500
  • 52 Week's Low
  • ₹ 3,870.1
  • Book Value
  • ₹ 509.61
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 8,487.41
  • P/E
  • 36.99
  • EPS
  • 138.23
  • Divi. Yield
  • 1.86

Procter & Gamble Health Ltd Corporate Actions

17 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Apr , 2023

12:00 AM

17 Mar , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Feb , 2023

12:00 AM

Dividend

Dividend amount: 45
Announcement date: 05 Feb , 2023

View Details

09 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

09 Jan , 2023

12:00 AM

09 Sep , 2022

12:00 AM

AGM

Announcement date: 09 Sep , 2022

View Details

29 Aug , 2022

12:00 AM

Dividend

Dividend amount: 11.5
Announcement date: 29 Aug , 2022

View Details

07 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Oct , 2022

12:00 AM

08 Sep , 2022

12:00 AM

BookCloser

View Details

Procter & Gamble Health Ltd News and Update

Image not found
  • 27 September, 2023 |
  • 8:33 PM

A 51% stake in TCNS Clothing has been acquired by Aditya Birla Fashion Retail Ltd (ABFRL), making it a promoter of the women's clothing company.

Image not found
  • IIFL News Service |
  • 26 September, 2023 |
  • 8:31 PM
Image not found
Article Image
  • IIFL News Service |
  • 22 September, 2023 |
  • 8:26 PM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Procter & Gamble Health Ltd SHAREHOLDING SNAPSHOT
30 September , 2023 | 02:03 AM

PROMOTER - TOTAL51.82%

Indian: 0.00%

Foreign: 51.8156%

NON-PROMOTER - TOTAL 48.18%

Institutions: 19.45%

Non-Institutions: 28.74%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Procter & Gamble Health Ltd FINANCIALS

No Data Available To Display Chart

Procter & Gamble Health Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Procter & Gamble Health Ltd

  • S N Talwar
  • Chairman & Independent Directo
  • Rani A Jadhav
  • Independent Director
  • Milind Thatte
  • Managing Director
  • Amit Gupta
  • Director (Finance) & CFO
  • Aalok Agrawal
  • Director
  • Zeal Shah
  • Company Sec. & Compli. Officer
  • Elizabeth Desmond
  • Director
  • S Madhavan
  • Independent Director
  • Lokesh Chandak
  • Executive Director
  • Seema Sambasivan
  • Non Executive Director

Summary

Procter & Gamble Health Limited (formerly Merck Limited), is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals. The company is the supplier of Pharmaceutical Chemicals, Formulated Chemical Products, Chemicals, Industrial Chemicals, Chemicals, Pharmaceutical Industry, and Chemical Products. The company offers prescription drugs, biotechnology products, and consumer health products, including over-the-counter products. They also offer products for the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases, and other conditions with unmet medical needs.The company operates in two business divisions, namely Pharmaceuticals and Chemicals. The Pharmaceuticals business comprises of Ethicals used in the treatment of Cardiovascular and Metabolic diseases & Vitamin-based formulations and Consumer Health Care Products. The Chemicals business comprises of Bulk Drugs and Pigments. Segment revenue relating to the Chemicals business consists of bulk drugs, pigments and active pharmaceutical ingredients.Merck Ltd was incorporated in the year 1967 as E Merck (India) Ltd. The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities. The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations.The company started their operations as a manufacturer of... Read More


Reports by Procter & Gamble Health Ltd


Reports by Procter & Gamble Health Ltd

Company FAQ

No Record Found